This trial is active, not recruiting.

Conditions cancer related-risks, risk perception, survey, focus group
Treatments interviews, focus group, survey
Sponsor Memorial Sloan Kettering Cancer Center
Collaborator National Cancer Institute (NCI)
Start date September 2001
End date December 2017
Trial size 1514 participants
Trial identifier NCT00588211, 01-121, CA93182


The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Center and Adelphi University are working together to design a new measure. Findings from this study will help us find new ways to help people avoid cancer.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Time perspective prospective
We will recruit fifteen New York University College of Dentistry (NYUCD) clinic patients who report current tobacco use.
45-minute individual interviews after the conclusion of their dental appointment
Second, we will recruit thirty dental clinic smokers (10 per day for 3 days) from the NYUCD waiting room.
focus group
A focus group of the preliminary cancer-related risk perception item pool.
Third, we will survey 200 student participants from Adelphi University.
Quantitative item analysis of the final item pool.
Queens Hospital Center with 800 patients.
A second confirmatory factor analysis.

Primary Outcomes

Develop a comprehensive "blueprint," or description of the cancer-related risk perception construct; to use it to generate a cancer-related risk perception item pool; conduct an analysis of the generated items
time frame: 3 years

Secondary Outcomes

to establish initial evidence for scale reliability and validity
time frame: 3 years

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Subject must be >= to 18 years of age - For recruitment at Adelphi University: Speak English - For recruitment at Queens Hospital Center: Speak English - For recruitment at Queens Hospital Center: Must be a Queens Hospital Center Patient Exclusion Criteria: - Patients who have a history of colorectal cancer at the Queens Hospital Center - Patients who cannot give informed consent

Additional Information

Official title Measurement of Cancer-Related Risk Perception in Smokers
Principal investigator Jennifer L Hay, PhD
Description The goal of the study is to develop and provide initial evidence for the reliability and validity of a measure of cancer-related risk perception. As such, the primary outcomes of the study will be initial construct validity (convergent validity and discriminant validity) of the proposed scale as evidenced by correlations of this test with other tests that vary in the degree of association to the proposed construct of cancer-related risk perception. It is anticipated that the cancer-related risk perception scale will correlate most highly (.50-.60) with measures of tobacco and environmental risk exposures, readiness to quit smoking, and family cancer history.
Trial information was received from ClinicalTrials.gov and was last updated in November 2016.
Information provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center.